Bulletin of Experimental Biology and Medicine

, Volume 85, Issue 3, pp 362–366 | Cite as

Effect of rhythm of administration of 1,2-dimethylhydrazine on its carcinogenic activity

  • K. M. Pozharisskii
  • V. N. Vokhmyanin
  • N. A. Kulakov
  • R. M. Balanski
  • A. Ya. Likhachev
  • A. S. Petrov
  • Ya. D. Shaposhnikov
Oncology
  • 10 Downloads

Abstract

The rhythm of injection of 1,2-dimethylhydrazine (DMH), in the same total dose, affects the ultimate carcinogenic effect. The most widespread development of intestinal tumors is observed if DMH is given once a week in a dose of 21 mg/kg body weight. Daily injection in a dose of 3 mg/kg leads to less marked tumor development, limited to the large intestine. However, under these conditions pronounced degenerative and necrobiotic, and in a few cases neoplastic changes develop in the liver. The frequent administration of small doses of the carcinogen leads to a marked decrease in the cytochrome P450 content in the microsomes of the liver; this evidently delays the metabolism of DMH, its conversion into its end product, and binding of the latter with macromolecules of the enterocytes.

Key Words

metabolism of 1,2-dimethylhydrazine intestinal tumors rhythm of administration of carcinogen cytochromes P450 and b5 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    K. M. Pozharisskii, Yu. M. Kapustin, A. Ya. Likhachev, et al., Vopr. Onkol., No. 1, 69 (1974).Google Scholar
  2. 2.
    K. M. Pozharisskii, Yu. M. Kapustin, A. Ya. Likhachev, et al., (K. M. Pozharisski et al.), Int. J. Cancer15, 673 (1975).Google Scholar
  3. 3.
    K. M. Pozharisskii, Ya. D. Shaposhnikov, A. S. Petrov, et al. (K. M. Pozharisski et al.), Z. Krebsforsch.,87, 67 (1976).Google Scholar
  4. 4.
    D. S. Sarkisov, A. A. Pal'tsyn, and B. V. Vtyurin, The Adaptive Modification of Biorhythms [in Russian], Moscow (1975).Google Scholar
  5. 5.
    H. Druckrey, in: Potential Carcinogenic Hazards from Drugs (UICC Monograph Series, Vol. 7), New York (1967), pp. 60–77.Google Scholar
  6. 6.
    H. V. Gelboin, Advances Cancer Res.,10, 1 (1967).Google Scholar
  7. 7.
    T. Narisawa and J. H. Weisburger, Proc. Soc. Exp. Biol. (New York),148, 166 (1975).Google Scholar
  8. 8.
    T. Omura and R. Sato, J. Biol. Chem.,239, 2370 (1964).Google Scholar
  9. 9.
    E. A. Smuckler, E. Arrhenius, and T. Hultin, Biochem. J.,103, 55 (1967).Google Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • K. M. Pozharisskii
  • V. N. Vokhmyanin
  • N. A. Kulakov
  • R. M. Balanski
  • A. Ya. Likhachev
  • A. S. Petrov
  • Ya. D. Shaposhnikov

There are no affiliations available

Personalised recommendations